Form 4: Oscar Health Executive Victoria Baltrus Reports Stock Transactions
SEC Form 4
Victoria Baltrus, Chief Accounting Officer of Oscar Health, reports the acquisition and disposal of Class A Common Stock, including transactions related to restricted stock units and tax obligations.
Summary
- On March 1, 2024, Victoria Baltrus exercised restricted stock units (RSUs) to acquire Class A Common Stock.
- These transactions involved the vesting of 4,121, 4,811, and 7,500 RSUs, each representing one share of Class A Common Stock.
- Additionally, 75,643 restricted stock units vested on March 1, 2024, following the Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
- On March 4, 2024, Ms. Baltrus sold 33,707 shares of Class A Common Stock at a weighted average price of $15.88 to cover tax obligations related to the vesting of equity awards.
- The sales were executed under a pre-existing Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The transactions are routine and related to compensation and tax obligations. There's no indication of unusual activity or concern.
Positives
- The vesting of restricted stock units indicates that performance conditions were met, which could be viewed positively.
Negatives
- The sale of shares by an executive could be interpreted negatively by some investors, although it was done to cover tax obligations.
Risks
- Executive stock sales, even for tax purposes, can sometimes create short-term price volatility.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. They are closely monitored by investors for insights into management's perspective on the company's performance and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
- Sales of shares to cover tax obligations are a standard practice among executives receiving equity compensation.
- The use of Rule 10b5-1 trading plans is a common method for executives to manage their stock sales in compliance with insider trading regulations.
- Comparing Baltrus's transactions to those of executives at similar health insurance companies like UnitedHealth Group (UNH) or Humana (HUM) could provide context, but specific data on their transactions would be needed.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the potential for short-term price fluctuations.
Key Dates
| Date | Description |
|---|---|
| February 8, 2022 | Date of Power of Attorney execution. |
| June 1, 2022 | Start date for quarterly vesting of some restricted stock units. |
| September 1, 2022 | Date when 25% of some restricted stock units vested. |
| February 27, 2023 | Date prior to which the Rule 10b5-1 instruction letter was entered into. |
| June 1, 2023 | Start date for quarterly vesting of some restricted stock units. |
| March 1, 2024 | Date of restricted stock unit vesting and stock acquisition. |
| March 4, 2024 | Date of Class A Common Stock sale. |
| March 5, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.